108 related articles for article (PubMed ID: 2204510)
1. Serum aminoterminal type III procollagen peptide in early rheumatoid arthritis: relation to disease activity and progression of joint damage.
Eberhardt K; Thorbjorn Jensen L; Horslev-Petersen K; Pettersson H; Lorenzen I; Wollheim F
Clin Exp Rheumatol; 1990; 8(4):335-40. PubMed ID: 2204510
[TBL] [Abstract][Full Text] [Related]
2. Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritis.
Hørslev-Petersen K; Bentsen KD; Halberg P; Junker P; Kivirikko KI; Majamaa K; Risteli L; Risteli J; Lorenzen I
Clin Exp Rheumatol; 1988; 6(2):129-34. PubMed ID: 2846219
[TBL] [Abstract][Full Text] [Related]
3. Synovial fluid and serum concentrations of aminoterminal propeptide of type III procollagen in healthy volunteers and patients with joint disease.
Sharif M; George E; Dieppe PA
Ann Rheum Dis; 1996 Jan; 55(1):47-51. PubMed ID: 8572734
[TBL] [Abstract][Full Text] [Related]
4. Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis.
Hakala M; Aman S; Luukkainen R; Risteli L; Kauppi M; Nieminen P; Risteli J
Ann Rheum Dis; 1995 Nov; 54(11):886-90. PubMed ID: 7492237
[TBL] [Abstract][Full Text] [Related]
5. Procollagen Type I and III Aminoterminal Propeptide Levels and Severity of Interstitial Lung Disease in Mexican Women With Progressive Systemic Sclerosis.
Gonzalez-Lopez L; Rocha-Muñoz AD; Olivas-Flores EM; Garcia-Gonzalez A; Peguero-Gómez AR; Flores-Navarro J; Villa-Manzano AI; Zavaleta-Muñiz SA; Salazar-Paramo M; Mejía M; Juárez-Contreras P; Vazquez-Del Mercado M; Cardona-Muñoz EG; Trujillo-Hernández B; Nava-Zavala AH; Gamez-Nava JI
Arch Bronconeumol; 2015 Sep; 51(9):440-8. PubMed ID: 25301411
[TBL] [Abstract][Full Text] [Related]
6. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
7. Serial determinations of aminoterminal propeptide of type III procollagen (PIIINP) and prognosis in ovarian cancer; comparison to CA125.
Simojoki M; Santala M; Risteli J; Risteli L; Kauppila A
Anticancer Res; 2000; 20(6C):4655-60. PubMed ID: 11205196
[TBL] [Abstract][Full Text] [Related]
8. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment.
Meduri GU; Tolley EA; Chinn A; Stentz F; Postlethwaite A
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1432-41. PubMed ID: 9817690
[TBL] [Abstract][Full Text] [Related]
9. Serum N terminal procollagen III fragment: a predictive marker of joint destruction in rheumatoid arthritis?
Tebib JG; Viguier P; Noel E; Colson F; Barbier Y; Bouvier M
Clin Rheumatol; 1992 Dec; 11(4):502-7. PubMed ID: 1486740
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow fibrosis and disease activity in multiple myeloma monitored by the aminoterminal propeptide of procollagen III in serum.
Abildgaard N; Bendix-Hansen K; Kristensen JE; Vejlgaard T; Risteli L; Nielsen JL; Heickendorff L
Br J Haematol; 1997 Dec; 99(3):641-8. PubMed ID: 9401078
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum PIIINP and laminin in inflammatory bowel disease indicate hepatobiliary and pancreatic dysfunction.
Heikius B; Niemelä O; Niemelä S; Karttunen TJ; Lehtola J
Hepatogastroenterology; 2002; 49(44):404-11. PubMed ID: 11995461
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of laminin P1 and aminoterminal propeptide of type III procollagen in sickle cell disease.
Bolarin DM; Swerdlow P; Wallace AM; Littsey L
Haematologia (Budap); 1998; 29(1):51-8. PubMed ID: 9704258
[TBL] [Abstract][Full Text] [Related]
13. Different effects of thyroid disease on serum levels of procollagen III N-peptide and hyaluronic acid.
Faber J; Hørslev-Petersen K; Perrild H; Lorenzen I
J Clin Endocrinol Metab; 1990 Oct; 71(4):1016-21. PubMed ID: 2401705
[TBL] [Abstract][Full Text] [Related]
14. Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients.
Boffa MJ; Smith A; Chalmers RJ; Mitchell DM; Rowan B; Warnes TW; Shomaf M; Haboubi NY
Br J Dermatol; 1996 Oct; 135(4):538-44. PubMed ID: 8915142
[TBL] [Abstract][Full Text] [Related]
15. Aminoterminal propeptide of type III procollagen and hyaluronan in patients with primary biliary cirrhosis: markers of fibrosis in primary biliary cirrhosis.
Remmel T; Remmel H; Salupere V
J Gastroenterol Hepatol; 1996 Nov; 11(11):1016-20. PubMed ID: 8985819
[TBL] [Abstract][Full Text] [Related]
16. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics.
Zachariae H; Søgaard H; Heickendorff L
Acta Derm Venereol; 1989; 69(3):241-4. PubMed ID: 2566230
[TBL] [Abstract][Full Text] [Related]
17. [Levels of procollagen type III n-terminal peptide (PIIINP) in serum of patients with myeloproliferative syndrome (mps)].
Podolak-Dawidziak M; Wróbel T; Jeleń M
Pol Arch Med Wewn; 1998 Jan; 99(1):24-9. PubMed ID: 9686500
[TBL] [Abstract][Full Text] [Related]
18. Serum aminoterminal type III procollagen peptide reflects repair after acute myocardial infarction.
Jensen LT; Hørslev-Petersen K; Toft P; Bentsen KD; Grande P; Simonsen EE; Lorenzen I
Circulation; 1990 Jan; 81(1):52-7. PubMed ID: 2297848
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronan and procollagen type III aminoterminal peptide in serum and bronchoalveolar lavage fluid from patients with pulmonary fibrosis.
Milman N; Kristensen MS; Bentsen K
APMIS; 1995 Oct; 103(10):749-54. PubMed ID: 8534435
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis.
Scheja A; Akesson A; Hørslev-Petersen K
Scand J Rheumatol; 1992; 21(1):5-9. PubMed ID: 1570489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
